CME/CE

Episodes 376-390 of 897

• 

  MinuteCE®

  Index of Suspicion

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  0.50 credits 2 episodes

• 

  RestartResume

  Chemoradiotherapy Toxicities: How Do They Impact Starting Immunotherapy?

  MinuteCE®

  Chemoradiotherapy Toxicities: How Do They Impact Starting Immunotherapy?

  • 

    

    Joshua E. Reuss, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Introduction to Right Heart Catheterization

  MinuteCE®

  Introduction to Right Heart Catheterization

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  0.50 program credits

• 

  RestartResume

  Pre-Test Probability

  MinuteCE®

  Pre-Test Probability

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  0.50 program credits

• 

  RestartResume

  Evaluating The Wave Forms

  MinuteCE®

  Evaluating The Wave Forms

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Victor Moles, MD

    Peer

  1.75 program credits

• 

  RestartResume

  Vasodilator Challenge

  MinuteCE®

  Vasodilator Challenge

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Richard Krasuski, MD

    Peer

  1.75 program credits

• 

  RestartResume

  Preparing Your Patient for the Procedure

  MinuteCE®

  Preparing Your Patient for the Procedure

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Victor Moles, MD

    Peer

  0.50 program credits

• 

  RestartResume

  Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC

  MinuteCE®

  Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC

  • 

    

    Jhanelle E. Gray, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Tips to "Thinking Well While In The Catheter Lab"

  MinuteCE®

  Tips to "Thinking Well While In The Catheter Lab"

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Richard Krasuski, MD

    Peer

  0.50 program credits

• 

  MinuteCE®

  Walking Through the Right Heart Catheterization Procedure

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Victor Moles, MD

    Peer

  • 

    

    Richard Krasuski, MD

    Peer

  1.75 credits 6 episodes

• 

  RestartResume

  Relationship Between RHC Variables and Prognostic Outcome

  MinuteCE®

  Relationship Between RHC Variables and Prognostic Outcome

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Richard Krasuski, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Unresectable Stage III NSCLC: Highlights From the Oncology Meeting in Chicago 2024

  MinuteCE®

  Unresectable Stage III NSCLC: Highlights From the Oncology Meeting in Chicago 2024

  • 

    

    Joshua E. Reuss, MD

    Peer

  • 

    

    Jhanelle E. Gray, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Evaluating Potential CHD Patients

  MinuteCE®

  Evaluating Potential CHD Patients

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Richard Krasuski, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Immunotherapy Approaches in Unresectable Stage III NSCLC: What’s on the Horizon?

  MinuteCE®

  Immunotherapy Approaches in Unresectable Stage III NSCLC: What’s on the Horizon?

  • 

    

    Jhanelle E. Gray, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Consolidation Immunotherapy After Concurrent CRT: What Do Real-World Data Show? 

  MinuteCE®

  Consolidation Immunotherapy After Concurrent CRT: What Do Real-World Data Show? 

  • 

    

    Jhanelle E. Gray, MD

    Peer

  1.00 program credits

• Prev
• 1
• 2
• …
• 24
• 25
• 26
• 27
• 28
• …
• 59
• 60
• Next